[28PS3-pm] Drug delivery system in oncotherapy 2

Tue. Mar 28, 2023 2:00 PM - 3:00 PM [Room PS3] (2F)

Chair: Hidemasa Katsumi, Shoichiro Asayama

+Add all to schedule

2:00 PM - 2:12 PM

[28PS3-pm01S] Antitumour effect of Doxorubicin-encapsulated liposome-loaded spleen cells.

○Yuki Matsugi¹, Taro Shimizu¹, Hidenori Ando¹, Yu Ishima¹, Tatsuhiro Isida¹ (1. Grad. Sch. Biomed. Sci., Tokushima Univ.)

2:12 PM - 2:24 PM

[28PS3-pm02S] Development of gold nanorod-sulfated hyaluronic acid complexes for cancer-targeted photothermal therapy

○Toshie Tanaka¹, Kohei Sano¹, Masayuki Munekane^1,2, Toshihide Yamasaki¹, Takahiro Mukai¹ (1. Kobe Pharm. Univ., 2. Grad. Sch. Pharm. Kanazawa Univ.)

2:24 PM - 2:36 PM

[28PS3-pm03S] Elucidation of the mechanism of virus infection-independent anti-tumor effects of oncolytic adenovirus serotype 35.

○Sora Tokuoka¹, Ryosuke Ono², Masashi Tachibana^1,2, Fuminori Sakurai^1,2, Hiroyuki Mizuguchi^1,2,3,4,5,6 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI, Osaka Univ., 5. MEI center, Osaka Univ., 6. CiDER, Osaka Univ.)

2:36 PM - 2:48 PM

[28PS3-pm04S] Polymethoxyflavonoids enhance antitumor effects of Antibody-Drug Conjugate

○Tomoya Masuoka¹, Takumi Iwasawa¹, Takayuki Yonezawa², Akio Watanabe³, JeTae Woo², Kazunori Kato¹ (1. Grad. Sch. Sci. Eng., Toyo Univ., 2. Grad. Sch. Biotech., Chubu Univ.,, 3. Jumonji Univ.,)

2:48 PM - 3:00 PM

[28PS3-pm05S] Combination of model antigen-loaded albumin nanoparticles and adjuvants induces effective cancer therapeutic effects.

○Rina Yamade¹, Taro Shimizu¹, Naoki Hirakawa¹, Hidenori Ando¹, Yu Ishima¹, Tatsuhiro Ishida¹ (1. Grad. Sch. Biomed. Sci., Tokushima Univ.)

Session information